United States L'EVEQUE Forrest Baptista Sturt University Medical Center Bayard · Powell, Dr. day in Chicago, United States society of Clinical Oncology meeting in standard therapy in the United States as Avalon pharmaceuticals company production of soft
Cream drug, can extend promyelocytic leukemia patients ' lives, prevent disease recurrence. He stressed: "therapeutic doses of arsenic is much smaller than that usually gives a small dose of poison. ”
Promyelocytic leukemia or APL is acute myelogenous leukemia. United States each year, approximately 1500 people suffer from acute myeloid leukemia. APL's standard therapy is receiving chemotherapy and taking vitamin A derivatives on type, as the net acid.
Powell and colleagues in the United States National Cancer Institute sponsored through three years study concluded that the above conclusions. They had just been diagnosed with Leukemia patients are divided into two groups, one group only accepts standard therapy, a set of accepted standard therapies at the same time taking very little arsenic.
The results showed that the first group of 257 patients have 66 people out of leukemia, another group of 261 patients have fully recovered of 81. "In those patients taking arsenic, only 5 people or about 2% of patients relapse," Powell said.
Powell believes that arsenic as APL patients after chemotherapy drug of choice. He said that future research will be placed in the test can chemotherapy patients, only taking arsenic drug therapy.
No comments:
Post a Comment